Sr. Director/Director, Health Economics and Market Access

Skip To Job Description Cytovale Thanks for visiting our Career Page. Please review our open positions and apply to the positions that match your qualifications. Sr. Director/Director, Health Economics and Market Access Remote Full Time Senior Manager/Supervisor Share About the Company: Cytovale is a leading innovator in early sepsis detection, revolutionizing emergency care with its advanced IntelliSep technology. This system provides rapid, actionable insights into a patient's likelihood of having or developing sepsis through a quick 8-minute blood test. IntelliSep's unique capability to assess immune dysregulation enhances the triage and treatment of sepsis, promoting patient-centered care, operational efficiencies, and provider satisfaction. Cytovale is committed to the successful implementation, clinical adoption, and continual improvement of healthcare outcomes. For more information, please visit www.cytovale.com.Position Overview: Cytovale is hiring a Sr/Director of Healthcare Economics and Market Access to own the IntelliSep ROI narrative and turn it into a repeatable, defensible tool that drives adoption and expansion across health systems. This role goes beyond a traditional health economics and market access (HEMA) function. In addition to the standard HEMA scope (coding, coverage, payer strategy, evidence generation support), this person will work directly with hospital finance, coding, and revenue cycle teams to communicate, find, and help capture value that IntelliSep enables, but that hospitals often leave on the table.This is a hybrid clinical economics and revenue cycle role. The ideal candidate can build a rigorous financial model, grounded in clinical outcomes, defend it in front of a C-suite audience, and then roll up their sleeves with a hospital's coding and billing team to chase down specific dollars, whether that means fighting DRG downgrades and payer denials tied to sepsis coding, identifying incomplete or missed code capture, or surfacing other value opportunities created by earlier and more accurate identification of patients that have or don’t have sepsis.Key Responsibilities:Own and Evolve the ROI StoryBuild, maintain, and continuously refine the core IntelliSep economic model and value narrative, incorporating new clinical evidence, coding and reimbursement changes, and customer-specific data as they become available.Translate clinical outcomes data (length of stay, mortality, antibiotic timing, resource utilization) into financial terms that resonate with health system CFOs, CMOs, and CQOs.Maintain a set of modular ROI tools (calculators, one-pagers, board-ready decks) that can flex to a given system's payer mix, cost structure, and sepsis program KPIs.Engage with Hospital System Executive LeadershipServe as Cytovale's primary voice on economic value in front of hospital system C-suite and finance leadership, including CFOs, VPs of revenue cycle, and quality/finance committees.Partner with sales and marketing to prepare and deliver executive-level business reviews and value-realization presentations at target accounts.Represent Cytovale's economic point of view at conferences, KOL events, and payer or health system forums as needed.Identify and Pursue Revenue Cycle Opportunities with CustomersWork directly with hospital coding, billing, and revenue cycle teams to identify sepsis-related coding and documentation gaps, including incomplete severity of illness capture, missed comorbidity/complication (CC/MCC) coding, and documentation gaps that affect DRG assignment.Help customers understand and contest inappropriate DRG downgrades and payer denials connected to sepsis diagnoses, providing supporting clinical and coding rationale where appropriate.Build repeatable playbooks and audit approaches that hospital partners can use on their own coding and billing data to find these opportunities systematically, not just once.Identify...